FDA's Office Of Criminal Investigations May Undergo Overhaul With The Resignation of Its Director
This article was originally published in The Pink Sheet Daily
Executive Summary
Terry Vermillion, who has headed up the office for 18 years, resigned two months after a whistleblower complaint about him was made public.